Abridge AI private stock trade

Abridge AI

Legal NameAbridge AI, Inc.
HeadquartersPittsburgh, PA
SectorHealthTech

Abridge is a healthcare technology company specializing in improving patient-provider communication through advanced audio and transcription solutions. The company offers a platform that records and summarizes medical conversations during patient visits, enabling patients to better understand their health information and care plans. Abridge’s technology focuses on enhancing the patient experience by providing clear and accessible summaries of medical discussions, ensuring that patients can retain important information after appointments. The platform aims to empower individuals to take an active role in their healthcare journey and improve overall health outcomes through better communication and understanding.

Learn more about Abridge AI IPO.

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get Access
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for and trade Abridge AI, contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get Access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for and trade Abridge AI, contact us to request access.

Similar Companies

View More

ZXData is a leading provider of real-time secondary data on private companies. ZXData's dataset incoroporates closed trades with 20bn+ in volume. In addition, it incorporates $200bn+ of buy/sell prices and $56bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.

Disclaimer

This report is provided for informational purposes only and does not constitute a recommendation or solicitation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. The values shown in this report are not indicative price quotations. This report does not constitute investment advice, nor does this report constitute a "research report" as defined by FINRA Rule 2241 or a "debt research report" as defined by FINRA Rule 2242.

The ZXData and the information contained in this report, some of which have been obtained from third-party sources, are provided on an "as is" basis and the user of this information assumes the entire risk of any use made of this information. Neither Zanbato Inc. (“Zanbato”) nor its affiliates guarantee the accuracy or completeness of the data contained in this report, or its computation and compilation.

The ZXData and this report constitute Zanbato’s valuable intellectual property. You are expressly prohibited from copying, modifying, transmitting or redistributing the ZXData or this report without Zanbato’s prior written consent.